Related Experiment Video
Updated: Feb 22, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
All Paths Lead to TRIM25
Hengbo Zhou1, James C Costello2
1Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Cancer Biology Program, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Abstract:
Identifying key factors that regulate the transition from primary to metastatic cancer is a fundamental challenge. Walsh et al. took a systems biology approach integrating computational, in vitro, and in vivo experiments to identify TRIM25 (tripartite motif containing 25) as a key factor that regulates metastatic gene signatures both at the transcriptional and post-transcriptional level in breast cancer. Targeting TRIM25 therapeutically is attractive because it governs a broad set of coordinated transcriptional modules that dictate metastatic progression.
Insights
Researchers identified tripartite motif containing 25 (TRIM25) as a key regulator of breast cancer metastasis. Targeting TRIM25 may offer a therapeutic strategy to control the spread of cancer by modulating metastatic gene expression.
Area of Science:
- Oncology
- Molecular Biology
- Systems Biology
Background:
- Metastasis is a complex process driven by specific gene expression changes.
- Identifying key regulators of metastatic gene signatures is crucial for developing effective cancer therapies.
Purpose of the Study:
- To identify key factors regulating the transition from primary to metastatic breast cancer.
- To investigate the role of tripartite motif containing 25 (TRIM25) in controlling metastatic gene signatures.
Main Methods:
- A systems biology approach was employed, integrating computational, in vitro, and in vivo experiments.
- Analysis focused on identifying regulators of transcriptional and post-transcriptional metastatic gene signatures.
Main Results:
- Tripartite motif containing 25 (TRIM25) was identified as a key regulator of metastatic gene signatures in breast cancer.
- TRIM25 influences metastatic progression at both transcriptional and post-transcriptional levels.
Conclusions:
- TRIM25 plays a critical role in governing metastatic gene expression programs in breast cancer.
- Targeting TRIM25 presents a promising therapeutic avenue for controlling cancer metastasis due to its broad regulatory role.
More Related Videos
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
04:58Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
Published on: December 13, 2024
Related Concept Videos
Tail-anchoring of Proteins in the ER Membrane
Non-Canonical Wnt Signaling Pathways
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
The Intrinsic Apoptotic Pathway
Indirect Motor Pathways
The vestibulospinal tract originates in the vestibular nuclei of the brainstem. The vestibular system detects changes in...